Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten - 100 Swissmedic Key 68472006 Registration Holder Devatis AG Name Levodopa / Benserazid Devatis 250 mg (200 mg + 50 mg), Tabletten Date of registration 01.12.2021 Original/Generic Generic Introduction of Sequence 01.12.2021 ATC-Classification Levodopa and Decarboxylase Inhibitor (N04BA02) Revision date WHO WHO-DDD Valid until 30.11.2026 Index Therapeuticus (BSV) 01.08. Show package size 100 Index Therapeuticus (Swissmedic) 01.08. Description Swissmedic categorie. B SL Eintrag Yes Indication Information for professionals IP Consumer information Ex-factory-Price 17.44 Limitation No Deductible 10 % Consumer price 35.40 Feedback FB Daily cost GTIN 7680684720062 Medication Code Synthetika Pharmacode Disponibility
Composition benserazidum 50 mg ut benserazidi hydrochloridum, levodopum 200 mg, natrii docusas, E 172 (rubrum), ethylcellulosum, silica colloidalis anhydrica, cellulosum microcristallinum, amylum pregelificatum, mannitolum, calcii hydrogenophosphas, crospovidonum, magnesii stearas, pro compresso corresp. natrium 0.01035 mg. Packungsbestandteile Galenic Form Tabletten Active Agent Dose Benserazidum 50 mg Levodopa 200 mg
BAG: Active Agent Dose Benserazidum 50 mg Levodopa 200 mg
Inactive agents additional_information (Rubrum) Amylum Pregelificatum Calcii Hydrogenophosphas Cellulosum Microcristallinum Crospovidonum E 172 color. Ethylcellulosum Magnesii Stearas Mannitolum Natrii Docusas Pro Compresso Silica Colloidalis Anhydrica
Source Data was imported : 06.01.2022
Swissmedic Registration :
Sequence :
Product name :
Registration owner: :
Product group :
Index Therapeuticus (BSV) :
Medication Code :
Date of registration :
Valid until :
Package number :
Show package size :
Commercial Form/Unit :
Swissmedic categorie. :
Active Agents :
Composition :
